Barry Allen Stone

Title: The Innovations of Barry Allen Stone

Introduction

Barry Allen Stone is a notable inventor based in New Castle, DE (US). He has made significant contributions to the field of nucleic acid assays, showcasing his expertise and innovative spirit. With a focus on rapid and high-capacity methods, his work has the potential to impact various applications in molecular biology and infectious disease research.

Latest Patents

One of Barry Allen Stone's key patents is titled "Rapid, high capacity nucleic acid based assay." This patent describes a rapid and high-capacity method using chaotropic agents for evaluating nucleic acids. The method allows for the evaluation of samples containing target nucleic acids in a nucleic acid-based sandwich hybridization assay. This assay is performed in part within a chaotropic solution, which is subsequently removed prior to detecting and quantifying the product. The assay can be utilized to detect and quantify nucleic acid levels, as well as serve as an infectivity assay and evaluate the activity of anti-infectious agents.

Career Highlights

Barry Allen Stone is associated with E.I. du Pont de Nemours and Company, a leading science and technology company. His work at this organization has allowed him to develop and refine his innovative approaches to nucleic acid evaluation. His contributions have been instrumental in advancing the capabilities of molecular diagnostics.

Collaborations

Throughout his career, Barry has collaborated with notable colleagues, including Lee Terry Bacheler and Jeffrey Allan Miller. These collaborations have fostered an environment of innovation and have contributed to the successful development of his patented technologies.

Conclusion

Barry Allen Stone's work in the field of nucleic acid assays exemplifies the impact of innovation in scientific research. His patented methods not only enhance the efficiency of nucleic acid evaluation but also hold promise for various applications in health and disease management.